Literature DB >> 25232553

Pneumatosis cystoides intestinalis associated with toxic epidermal necrolysis: A case report.

Si-Yuan Yao1, Ryutaro Seo1, Tohru Nagano1, Kazuo Yamazaki1.   

Abstract

Toxic epidermal necrolysis (TEN) is a severe adverse drug reaction, which is characterized by erythema, blisters, and/or erosions of the mucous membranes and skin, but intestinal involvement is rare. In contrast, pneumatosis cystoides intestinalis (PCI) is a rare condition associated with a wide variety of underlying diseases, but to date no patient has presented with PCI associated with TEN. A 55-year-old man was admitted to intensive care unit for treatment of TEN caused by phenobarbital. On day 8 after admission, he presented with progressive abdominal distention and hypotension. Computed tomography (CT) showed gas in the superior mesenteric vein and air filled cysts in the walls of the small intestine. He was suspected of having septic shock due to PCI. As there were no indications of bowel ischemia or necrosis, the patient was managed conservatively with antibiotics and oxygen therapy. On day 10 after admission, he was weaned off catecholamines, with CT on day 11 showing complete resolution of gas in the superior mesenteric vein and air filled cysts. To our knowledge, this article describes the first patient presenting with PCI associated with TEN.

Entities:  

Keywords:  Conservative treatment; Intestinal involvement; Pneumatosis cystoids intestinalis; Septic shock; Toxic epidermal necrolysis

Year:  2014        PMID: 25232553      PMCID: PMC4163772          DOI: 10.12998/wjcc.v2.i9.469

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  13 in total

1.  Intestinal involvement in drug-induced toxic epidermal necrolysis.

Authors:  O Chosidow; J C Delchier; M T Chaumette; J Wechsler; P Wolkenstein; I Bourgault; J C Roujeau; J Revuz
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

2.  Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.

Authors:  Yumiko Yamane; Michiko Aihara; Zenro Ikezawa
Journal:  Allergol Int       Date:  2007-09-01       Impact factor: 5.836

Review 3.  Pneumatosis cystoides intestinalis: confirmation of diagnosis by endoscopic puncture a review of pathogenesis, associated disease and therapy and a new theory of cyst formation.

Authors:  J Höer; S Truong; N Virnich; L Füzesi; V Schumpelick
Journal:  Endoscopy       Date:  1998-11       Impact factor: 10.093

4.  Pneumatosis cystoides intestinalis in intestinal pseudoobstruction. Resolution after therapy with metronidazole.

Authors:  P P Tak; C M Van Duinen; P Bun; F Eulderink; J Kreuning; H G Gooszen; C B Lamers
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 5.  Pneumatosis intestinalis--a pitfall for surgeons?

Authors:  C Braumann; C Menenakos; C A Jacobi
Journal:  Scand J Surg       Date:  2005       Impact factor: 2.360

6.  Evaluation of HBO2 therapy in pneumatosis cystoides intestinalis.

Authors:  S Togawa; N Yamami; H Nakayama; M Shibayama; Y Mano
Journal:  Undersea Hyperb Med       Date:  2004       Impact factor: 0.698

Review 7.  Pneumatosis intestinalis: a review.

Authors:  B L Pear
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

Review 8.  Pneumatosis cystoides intestinalis. A review of the literature.

Authors:  S Galandiuk; V W Fazio
Journal:  Dis Colon Rectum       Date:  1986-05       Impact factor: 4.585

Review 9.  Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Authors:  Thomas Harr; Lars E French
Journal:  Orphanet J Rare Dis       Date:  2010-12-16       Impact factor: 4.123

10.  Surgical aspects of pneumatosis cystoides intestinalis: two case reports.

Authors:  Engelbert Schröpfer; Thomas Meyer
Journal:  Cases J       Date:  2009-08-12
View more
  1 in total

1.  "Cystamatic" Review: Is Surgery Mandatory for Pneumatosis Cystoides Intestinalis?

Authors:  M Brighi; S Vaccari; A Lauro; V D'Andrea; N Pagano; I R Marino; M Cervellera; V Tonini
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.